First-in-class programs to treat life threatening diseases
We are developing our clinical drug candidates for the treatment of autoimmune diseases and cancer, with cell products designed to overcome key limitations inherent to the manufacture, development and commercialization of other cell therapies
OUR PROMISE TO PATIENTS
We are committed to relentlessly pursuing and developing life-changing therapies, and making the future of cell therapy delivery both routine and accessible
Unmatched Science
Utilizing our iPSC (induced pluripotent stem cell) platform, we are advancing off-the-shelf, multiplexed-engineered cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function, and intended to deliver multiple therapeutic mechanisms to patients